Alkem Laboratories has introduced the original De Simone formulation to India, marking a strong move into the country’s fast-rising gut-health market. The launch comes at a time when digestive disorders are climbing and consumer awareness around...
Actimed Therapeutics today announced a licensing agreement with Mankind Pharma, giving the company exclusive rights to develop and commercialise Actimed’s products for the treatment and prevention of cachexia across India and several South Asian...
GSK plc and LTZ Therapeutics (LTZ), a biotechnology firm specializing in immunotherapy located in Redwood City, California, revealed a strategic research partnership aimed at enhancing the creation of innovative myeloid cell engagers (MCEs) to meet
Merck, referred to as MSD outside the U.S. and Canada, revealed top-line findings from the crucial double-blind phase 3 trial of the experimental, once-daily, oral, two-drug, single-tablet regimen of doravirine/islatravir [DOR/ISL (100 mg/0.25 mg)]
Pfizer has joined hands with the Pragyaan Sustainable Health Outcomes Foundation (PRASHO) to roll out a new series of migraine awareness and workplace productivity workshops across major corporate offices in Hyderabad. The initiative addresses...
HRV Pharma has announced a significant CDMO partnership with MetroChem API, marking one of India’s standout moves in advanced API development. Revealed today, the multi-year agreement positions HRV Pharma’s Virtual API platform alongside...
Under the brand name Lynkuet, elinzanetant has been authorized for marketing in the European Union (EU) by the European Commission. The medication is authorized for the management of moderate to severe vasomotor symptoms (VMS; also called hot flashes
Merck is placing a bold bet on Cidara’s experimental flu drug, expecting more than $5?billion in commercial potential as it moves to acquire the biotech firm for roughly $9.2?billion. The merger would provide Merck with CD388, a strain-independent..
Kailash Hospital & Heart Institute in Noida has been awarded the NABH Digital Health Gold Certification by the National Accreditation Board for Hospitals & Healthcare Providers, placing it among the country’s leading digital healthcare institutions
Roche revealed favorable phase III outcomes from the lidERA Breast Cancer trial assessing the experimental giredestrant as an adjunctive endocrine therapy for individuals with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")